Streetbeat News

Stock Prices

LAZR

Goldman Sachs analyst Mark Delaney has reiterated a Sell rating on Luminar Technologies (NASDAQ:LAZR) and reduced the price target from $3.5 to $3. This adjustment reflects a more bearish outlook on the company's stock by the investment bank.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:08 pm

XOS

Northland Capital Markets analyst Donovan Schafer has upgraded Xos (NASDAQ:XOS) from Market Perform to Outperform and set a price target of $0.75.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:07 pm

ADPT

Adaptive Biotechnologies' stock price is trading lower after the company reported third-quarter results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:05 pm

MNTK

Montauk Renewables' stock is trading lower after the company reported its third-quarter earnings, indicating a negative market reaction to the financial results.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:04 pm

GDOT

Green Dot Corporation's stock is trading lower following the company's announcement of a reduction in its adjusted earnings per share (EPS) guidance for the year 2023.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:03 pm

TMCI

Treace Medical Concepts' stock is trading lower following the release of their Q3 financial results, which fell short of expectations. Additionally, the company has revised its FY23 revenue guidance downward, setting it below analyst estimates.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:03 pm

LUCD

Lucid Diagnostics (NASDAQ:LUCD) is scheduled to release its quarterly earnings report on Monday, 2023-11-13, with analysts expecting an EPS of $-0.27. Investors are looking for an earnings beat and positive guidance for future growth. Historically, LUCD's stock price has been sensitive to earnings performance and guidance. Last quarter, LUCD beat the EPS estimate by $0.05, resulting in a 0.34% stock price increase the following day. Over the past year, LUCD shares have declined by 50.44%.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 4:02 pm

AWH

Aspira Womens Health (NASDAQ:AWH) is scheduled to release its quarterly earnings report on Monday, 2023-11-13, with analysts expecting an EPS of $-0.51. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, AWH's stock price has been sensitive to earnings performance and guidance rather than just earnings beats or misses. Last quarter, AWH beat the EPS estimate but saw a 7.61% drop in share price the following day. Over the last year, AWH shares have declined by 32.48%.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 4:02 pm

HOFV

Hall Of Fame Resort (NASDAQ:HOFV) is expected to release its quarterly earnings report on Monday, 2023-11-13, with an estimated EPS of $-2.48. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, HOFV's stock price has reacted negatively to earnings misses. The stock is currently trading at $2.73, down 82.71% over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 4:02 pm

OPAL

OPAL Fuels (NASDAQ:OPAL) is scheduled to release its quarterly earnings report on Monday, 2023-11-13, with an estimated EPS of $0.09. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, OPAL has had mixed earnings performance, with share price drops following both earnings misses and beats. Shares are currently trading at $5.7, down 29.35% over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 4:02 pm